Two Clinical Studies to be Presented at DDW 2014

//Two Clinical Studies to be Presented at DDW 2014

Redwood City, Calif. – May 2, 2014 – C2 Therapeutics, a privately held company founded to improve treatment of precursors to esophageal cancer, today announced that data from two clinical studies evaluating the therapeutic impact of its Coldplay Cryoballoon Focal Ablation System will be presented at Digestive Disease Week® (DDW®), on May 6th in Chicago, IL.

C2 Therapeutics DDW 2014 Clinical Study Announcement Card.

Click here for full press release.

2017-05-16T21:29:58+00:00